Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Abiomed, Inc., a leading player in the medical technology sector, is headquartered in the United States. Founded in 1981, the company has established itself within the medical, precision and optical instruments industry, focusing primarily on heart pump technology and cardiovascular support devices.
Abiomed is renowned for its innovative products, including the Impella heart pump, which offers unique benefits in minimally invasive heart procedures. This cutting-edge technology has positioned the company as a pioneer in the field, significantly enhancing patient outcomes in critical care settings.
With a strong market presence and a commitment to advancing heart recovery solutions, Abiomed continues to achieve notable milestones, solidifying its reputation as a trusted name in cardiovascular care.
67
DitchCarbon score
+35 vs industry average
Abiomed, Inc.’s score of 67 is higher than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Abiomed, Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Low
Medical Device Manufacturing has below-average carbon intensity
Industry performance
0.308
20182025
The Medical Device Manufacturing industry has reduced its overall emissions by 32% since 2018
Reported emissions
No reported emissions data is available for Abiomed, Inc. yet.
Abiomed, Inc.'s reported carbon emissions
Abiomed, Inc., headquartered in the US, operates in the Medical, precision and optical instruments, watches and clocks industry. While specific emissions data for Abiomed, Inc. is not available, the company demonstrates its commitment to climate action through Science Based Targets initiative (SBTi) approved targets.
Abiomed, Inc. (listed as A-BIO by SBTi) has committed to maintaining zero Scope 1 emissions through 2034, with 2023 as the base year. Furthermore, it aims to reduce absolute Scope 2 greenhouse gas (GHG) emissions by 58.8% by 2034, from a 2025 base year. These near-term targets are classified as consistent with reductions required to keep global warming to 1.5°C. Abiomed, Inc. also commits to measure and reduce its Scope 3 emissions. These SBTi commitments were approved using a streamlined validation route exclusive to small and medium-sized enterprises (SMEs).
Assessing Abiomed, Inc. as a supplier or portfolio company?
- See verified emissions data for over 2 million organizations
- View emissions forecasts for Abiomed, Inc. and the organizations you buy from or invest in
- Get PCAF data quality (DQ) scores, including for private organizations
Abiomed, Inc.’s Climate Goals (2030 & 2050)
2 goals2034
58.8% reduction in Scope 2
A-BIO commits to reduce absolute scope 2 GHG emissions 58.8% by 2034 from a 2025 base year.
Insufficient data58.8%
2034
A-BIO commits to maintain zero scope 1 emissions through 203…
A-BIO commits to maintain zero scope 1 emissions through 2034.
Insufficient data0%
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
Inherited from Johnson & Johnson2034 targetSee details
Active
Carbon Disclosure Project
Inherited from Johnson & JohnsonSign in to view
Active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
See details
Not active
RE 100
Inherited from Johnson & JohnsonSee details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Abiomed, Inc.8 days ago
67
Need this data for financed emissions?
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more